(Q34390294)

1 August 2017

1 reference

title

Antibody therapy of lymphoma. (English)

1 reference

1 August 2017

T M Illidge

1

1 reference

1 August 2017

M C Bayne

series ordinal

2

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

Expert Opinion on Pharmacotherapy

1 August 2017

published in

1 reference

1 August 2017

volume

2

1 reference

1 August 2017

issue

6

1 reference

1 August 2017

page(s)

953-961

1 reference

Treatment of non-Hodgkin's lymphoma

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.6.953

The emerging role of radioimmunotherapy in haematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.6.953

Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.6.953

CD20: a regulator of cell-cycle progression of B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.6.953

IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.6.953

Radioimmunotherapy of B-cell lymphoma with [131I]anti-B1 (anti-CD20) antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.6.953

21 January 2018

Identifiers

DOI

10.1517/14656566.2.6.953

1 reference

1 August 2017

1 reference